3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
3498
Neoplasms
2739
Prostatic Neoplasms
1583
Colorectal Neoplasms
1247
Lung Neoplasms
1188
Motor Activity
766
Head and Neck Neoplasms
621
Pancreatic Neoplasms
601
Colonic Neoplasms
586
Uterine Cervical Neoplasms
567
Carcinoma, Non-Small-Cell Lung
560
Carcinoma, Hepatocellular
558
Rectal Neoplasms
516
Stomach Neoplasms
493
Brain Neoplasms
436
Anxiety Disorders
401
Ovarian Neoplasms
399
Pain
376
Esophageal Neoplasms
347
Neoplasm Metastasis
340
Polycystic Ovary Syndrome
339
Fatigue
324
Urinary Bladder Neoplasms
314
Precursor Cell Lymphoblastic Leukemia-Lymphoma
303
Melanoma
298
Depression
286
Multiple Myeloma
283
Endometrial Neoplasms
263
Lymphoma
258
Hematologic Neoplasms
251
Interventions
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
OTHER
×
Embolism and Thrombosis
×
Clear all
NCT04657120
2025-12-23
HYDRA
Leiden University Medical Center
Phase NA
Completed
698 enrolled
NCT04304651
2024-12-16
MVTEP2/SOME2
University Hospital, Brest
Phase NA
Recruiting
1,276 enrolled